Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

SAREPTA THERAPEUTICS, INC.

Filed by SAREPTA THERAPEUTICS, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-15 06:26:11 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 16, 2025
Income
Not reported
Expenses
$320,000.00
Filing UUID
434d4074-3afb-46b9-ad6e-c8eab2729ae3
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to patient access to treatments Issues related to rare diseases such as Duchenne Muscular Dystrophy Issues related to newborn screening for rare diseases

PHA · Pharmacy

Issues related to the Inflation Reduction Acts prescription drug provisions

SCI · Science/Technology

Issues related to scientific innovation in healthcare such as gene therapies Issues related to artificial intelligence and data governance

TAX · Taxation/Internal Revenue Code

Tax issues related to research and development

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.